Hepb vacc 3 dose ped/adol im
Products billed under this code include Engerix-B Pediatric, Recombivax Hb.
Payment limit per 1 DOSE, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Engerix-B Pediatric, Recombivax Hb.
Payment limit per 1 DOSE, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Engerix-B Pediatric | GlaxoSmithKline | 58160-0820-11 | 10 | $332.20 |
| Engerix-B Pediatric | GlaxoSmithKline | 58160-0820-52 | 10 | $332.20 |
| Recombivax Hb | Merck | 00006-4094-09 | 6 | $199.32 |
| Recombivax Hb | Merck | 00006-4981-00 | 10 | $332.20 |
| Recombivax Hb | Merck | 00006-4995-41 | 10 | $332.20 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $33.22 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted September 17, 2026 |
| 3Q26 | $33.22 | +$0.016 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted September 15, 2026 |
| 2Q26 | $33.204 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted September 15, 2026 |
| 1Q26 | $33.204 | +$1.533 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted September 15, 2026 |
| 4Q25 | $31.671 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted September 8, 2026 |
| 3Q25 | $31.671 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted March 10, 2026 |
| 2Q25 | $31.671 | +$0.901 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted March 10, 2026 |
| 1Q25 | $30.77 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted December 19, 2025 |
| 4Q24 | $30.77 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted June 11, 2025 |
| 3Q24 | $30.77 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted June 11, 2025 |
| 2Q24 | $30.77 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted March 11, 2025 |
| 1Q24 | $30.77 | +$0.875 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted December 19, 2024 |
| 4Q23 | $29.895 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted October 10, 2024 |
| 3Q23 | $29.895 | −$1.151 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted June 5, 2024 |
| 2Q23 | $31.046 | +$1.151 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted February 23, 2024 |
| 1Q23 | $29.895 | +$0.852 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted December 6, 2023 |
| 4Q22 | $29.043 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted June 22, 2023 |
| 3Q22 | $29.043 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted June 9, 2023 |
| 2Q22 | $29.043 | +$0.286 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted December 14, 2022 |
| 1Q22 | $28.757 | +$0.538 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted June 8, 2022 |
| 4Q21 | $28.219 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted June 2, 2022 |
| 3Q21 | $28.219 | $0.00 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted June 2, 2022 |
| 2Q21 | $28.219 | +$0.011 | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted March 1, 2022 |
| 1Q21 | $28.208 | – | 1 DOSE | Hepb vacc 3 dose ped/adol im | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.